+ 49 (0) 2204 2918806
Manufacturer: GlobalData

Enzo Life Sciences, Inc. - Product Pipeline Analysis

SKU:GDME100341PD / 329299
Publication Date:28.12.2012
Language version:English
Lieferzeit:2-3 Tage
Nr of pages:19 pages
Rating:Für diese Studie liegt keine Bewertung vor.
$750.00   *
* Click here to switch the currency you want to pay in.
More about this report
Table of Contents
Other relevant reports
Our guarantee

Numbers and facts for this report

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Content of the report

Enzo Life Sciences, Inc. (Enzo Life Sciences) is a wholly owned subsidiary of Enzo Biochem, Inc. The company provides life science research reagents. Enzo Life Sciences also offers labeling and detection technologies throughout research and diagnostic fields. The company's product portfolio include fluorescent dyes, assay kits, small molecules, proteins, antibodies, proteins, peptides and other related compounds. It offers tools for life science researchers, which includes high content analysis, drug discovery, gene expression analysis, target identification/validation, nucleic acid detection and cellular analysis, among others. Enzo Life Sciences is headquartered in Farmingdale, New York, the US.

The company intends to expand its product portfolio as recently it launched Leading Light, a drug discovery screening platform.

This report is a source for data, analysis and actionable intelligence on the Enzo Life Sciences, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.